Review on the Application of Biologic Factors in Atopic Dermatitis and Chronic Spontaneous Urticaria
Aikaterini Salavoura · 2026
Read Review on the Application of Biologic Factors in Atopic Dermatitis and Chronic Spontaneous Urticaria by Aikaterini Salavoura (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13284276.txt.
Description
Biologic drugs for stubborn eczema and hives are weighed by Aikaterini Salavoura in a 2026 review of trial and real-world proof. Severe cases are uncommon yet costly and burdensome for patients. Antibody drugs transformed other skin diseases, but these two conditions follow tangled cytokine networks.
Dupilumab leads eczema care, helping a large share of severe cases in trials. Three further approved options serve as alternatives for eczema patients. For chronic hives, omalizumab holds guideline backing as an add-on therapy. Debate over its true benefit in hives continues in the literature. Disease subtype knowledge should guide precise drug choice ahead.
Catalog record
| CREATOR | Aikaterini Salavoura |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 81620 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |